| Date | Title | Description | Source |
| 09.04.2024 | Q1 2024 Digital Health Funding: A Reset & Refocus on Out... | What You Should Know:
– Q1 2024 Digital health funding in the U.S. reached $2.7B across 133 deals, w... | hitconsult... |
| 08.04.2024 | Healthtech investing still lags behind even as funding grew ... | Investments went up 42% from Q4 to $2.7B, but they're down 20% from the $3.4B in Q1 2023
2023 was a ... | vator.tv/n... |
| 02.02.2023 | Clinical trial company Science 37 buys life science assets f... | Photo: Martin Barraud/Getty Images | mobihealth... |
| 02.02.2023 | Science 37 Acquires Vault Health’s Life Sciences Platform To... | Science 37 Holdings, the industry-leading Metasite, announced that it has acquired the life sciences... | aithority.... |
| 02.02.2023 | Clinical trial company Science 37 buys life sciences platfor... | The company says the purchase will accelerate its development plans for workflow features
When it co... | vator.tv/n... |
| 19.10.2022 | Decentralization in Action: What Oncology Trials Look Like N... | Oncology trials have especially benefited with DCT practices.
TORONTO (PRWEB) October 19, 2022
The a... | prweb.com/... |
| 13.09.2022 | How Agile Clinical Trials Unlock Universal Access to Rare Di... | Science 37’s research shows that rare diseases will be among the most prevalent categories for incor... | prweb.com/... |
| 02.05.2022 | Oncology Clinical Trial Access — Increasing Participation of... | Research suggests that social determinants of health, poverty, physician bias, patient study burden ... | prweb.com/... |
| 13.01.2022 | Science 37 : reg; to Become Publicly Listed via Merger… | Transaction values Science 37 at an enterprise value of approximately $1.05 billion at closing
Posit... | marketscre... |
| 17.11.2021 | Science 37 : reg; Reports Quarterly Financial Results for th... | November 15
Science 37 Holdings, Inc. (Nasdaq: SNCE) today reported its financial results for the qu... | marketscre... |
| 15.11.2021 | Science 37 : Reports Quarterly Financial Results for the Per... | Science 37 Reports Quarterly Financial Results for the Period Ended September 30, 2021
LOS ANGELES, ... | marketscre... |
| 22.10.2021 | Veta Health Apoints CEO, Walgreens Leadership Appointments, ... | James Sutcliffe, CEO at Veta Health
Veta Health, a global provider of digital solutions for remote p... | hitconsult... |
| 14.10.2021 | Lifesci Acquisition II : Science 37, the Operating System fo... | Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci... | marketscre... |
| 07.10.2021 | LifeSci Acquisition II : Science 37, the Operating System fo... | Science 37 to debut on Nasdaq as a publicly traded company under ticker symbol “SNCE”
Business combi... | marketscre... |
| 07.10.2021 | Science 37 Closes Business Combination with LifeSci Acquisit... | Science 37, Inc., a Los Angeles, California-based provider of an Operating System for today’s agile ... | finsmes.co... |
| 07.05.2021 | LifeSci Acquisition II : Positions Science 37 with a balance... | Positions Science 37 with a balance sheet of up to $250 million to fund its decentralized trial tech... | marketscre... |
| 07.05.2021 | Science 37 Becomes Publicly Listed via SPAC | Science 37, Inc., the Los Angeles, CA-based developer of the Decentralized Clinical Trial Operating ... | finsmes.co... |
| 07.05.2021 | Clinical trial platform Science 37 is going public via a SPA... | The transaction will value the company at $1.05 billion
One of big trends of 2021 has been the emerg... | vator.tv/n... |
| 29.03.2021 | SYNEOS HEALTH, INC.
Syneos Health Partners with Science 37®... | MORRISVILLE, N.C. and LOS ANGELES, March 29, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), ... | marketscre... |
| 15.02.2021 | Decentralized Trials for Rare Diseases: Bringing Research to... | As we look ahead at continuing research in the post-pandemic era, a hybrid model leveraging patient-... | prweb.com/... |
| 26.01.2021 | Strategies that will help make 2021 a banner year for life s... | Pharma 4.0 is here to stay
As pharmaceutical executives continue to grapple with an ever-increasing ... | medcitynew... |
| 21.01.2021 | Science 37® Launches 'Science 37 Certified'--a Partnership P... | | prnewswire... |
| 10.09.2020 | Science 37® Launches Integrated Electronic Health Records in... | | prnewswire... |
| 21.08.2020 | Pharma giants back a leader in virtual clinical trial... | While traditional trial sites are under enormous pressure amid the Covid-19 pandemic, 3 pha... | endpts.com... |
| 21.08.2020 | StartUPDATES: New developments from healthcare startups | The SmartExam platform works like a virtual assistant to the provider, by guiding patients through a... | medcitynew... |
| 20.08.2020 | Science 37 Raises $40M in Funding | Science 37, a Los Angeles, CA-based provider of decentralized clinical trials, closed a $40m funding... | finsmes.co... |
| 20.08.2020 | Clinical Trials at Home? Science 37's Answer to Pharma's Pro... | Convincing people to take part in life-saving clinical drug trials was difficult even before the pan... | dot.la/cli... |
| 20.08.2020 | Science 37® Raises $40 Million to Extend Its Leadership in t... | | prnewswire... |
| 03.02.2020 | UK invests £65 million in international science projects hos... | UK invests £65 million in international science projects hosted by Fermilab
03-02-2020
Representativ... | cambridgen... |
| 31.05.2018 | Check out who joined StartUp Health Academy’s latest cohort... | Here’s an overview of the businesses based in part on StartUp Health’s blog post, info from the comp... | medcitynew... |
| 26.03.2018 | This is how AI will shape drug discovery | An oft-quoted statistic is that it takes 12 years and almost $2 billion dollars to bring an average ... | medcitynew... |
| 09.01.2018 | B Capital Group Partner: Pharma value chain will be area of ... | The Trump tax reform provisions offer some incentives for biopharma companies that add to the positi... | medcitynew... |
| 26.10.2017 | Bracket acquisition underscores the push to make clinical tr... | Adam Butler, Bracket strategic development and corporate marketing officer, said in an email that mP... | medcitynew... |
| 25.04.2017 | GV joins $29 million investment into Science 37 to bring cli... | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |
| 25.04.2017 |
Science 37 Gets $29M To Extend Clinical Trials To Patien... | Playa Vista-based Science 37, which is developing technology and a model that allows pharmaceuticals... | socaltech.... |
| 25.04.2017 | GV joins $29 million investment into Science 37 to bring cli... | Clinical trial technology company Science 37 has raised $29 million in a Series C round of funding l... | venturebea... |
| 25.04.2017 | GV Joins $29M Series C for Science 37 | PLAYA VISTA, Calif.--(BUSINESS WIRE)--Science 37, a trailblazing company focused on “site-less” clin... | citybizlis... |
| 25.04.2017 | Science 37 picks up $29 million more for remote clinical tri... | Remote clinical trial company Science 37 has raised $29 million in a round led by Glynn Capital Mana... | mobihealth... |
| 25.04.2017 | Science37 aims to democratize clinical research with a fresh... | Virtual clinical trials have come into their own thanks to widespread technology enabling patients o... | techcrunch... |
| 25.04.2017 | Science 37 raises a $29M Series C for “site-less” clinical t... | “We basically started with the question: ‘What’s best for patients?’” explained cofounder and CEO No... | medcitynew... |
| 25.04.2017 | Science 37 Raises $29M in Funding | Science 37, a Playa Vista, Calif.-based company focused on site-less clinical trials, raised $29m in... | finsmes.co... |
| 28.02.2017 | Lux Capital announces fresh $400 million fund to back ‘contr... | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn m... | venturebea... |
| 28.02.2017 | Lux Capital announces fresh $400 million fund to back ‘contr... | Lux Capital, a venture capital (VC) firm that makes “long-term bets on contrarians and outsiders,” h... | venturebea... |
| 19.01.2017 | What Pharma must do to win in Trump era | While Trump strongly criticized the pharmaceutical industry for both not manufacturing in the U.S. a... | medcitynew... |
| 23.12.2016 | Is the direct-to-patient model the future of clinical trials... | While this disintermediation is highly disruptive to existing players, the benefits to the consumer ... | medcitynew... |
| 18.10.2016 | Science 37 raises $31 million to bring clinical trials to th... | Clinical trial technology company Science 37 has raised $31 million in a series B round led by Redmi... | venturebea... |
| 18.10.2016 | Science 37 raises $31M from Sanofi, others for mobile clinic... | Mobile clinical trials company Science 37, which connects willing individuals to researchers so they... | mobihealth... |
| 18.10.2016 | Science 37 Raises $31M to Expand Virtual Clinical Trail Mode... | Science 37, Inc., a LosAngeles-based mobile technology and clinical trial startup that focuses on th... | hitconsult... |
| 18.10.2016 | Science 37 Completes $6.5M Series A Financing | Science 37, a Los Angeles, CA-based based technology-enabled clinical research company, completed a ... | finsmes.co... |
| 21.11.2015 | Take a memo, Andreessen Horowitz: 4 areas where it should co... | Other investments include Benchling, which develops collaborative tools for life science research, G... | medcitynew... |
| 20.10.2015 |
Science 37 Raises $6.5M
| Los Angeles-based Science 37, a provider of technology-enabled, clinical research services, has rais... | socaltech.... |
| 20.10.2015 | Clinical trial platform uses telemedicine, mobile tech to im... | “It’s a totally new type of operating model,” Craft said in a phone interview. “We use a nice, easy ... | medcitynew... |
| 20.10.2015 | Science 37 Completes $6.5M Series A Financing | Science 37, a Los Angeles based technology-enabled clinical research company, completed a $6.5m Seri... | finsmes.co... |
| 24.03.2011 | Science in the East gets a £70m boost from the Chancellor | Science in the East gets a £70m boost from the Chancellor
24-03-2011
Science in the East of England ... | cambridgen... |
| - | Take a memo, Andreessen Horowitz: 4 areas where it should co... | This week, Andreessen Horowitz said it’s launching a fund dedicated to investments in bioinformatics... | medcitynew... |
| - | StartUPDATES: New developments from healthcare startups | With an eye toward expanding patient access and growing market share while using existing clinical r... | medcitynew... |
| - | What Pharma must do to win in Trump era | “Getting away with murder” is a harsh condemnation of an industry dedicated to improving and saving ... | medcitynew... |
| - | Is the direct-to-patient model the future of clinical trials... | Black Friday, the day after Thanksgiving, is the biggest shopping day of the year in America. Accord... | medcitynew... |
| - | Startups taking new approaches to clinical trials have nette... | A medical technician handles coronavirus tests at the microbiology laboratory of Naples. Salvatore L... | businessin... |
| - | Check out who joined StartUp Health Academy’s latest cohort... | StartUp Health has added ten companies in the latest Academy cohort. The digital health companies in... | medcitynew... |
| - | Strategies that will help make 2021 a banner year for life s... | Under normal circumstances, the life sciences industry, while innovative, is weighed down by standar... | medcitynew... |
| - | Clinical trial platform uses telemedicine, mobile tech to im... | Science37, so named because 37C is the normal temperature of the human body, has raised a $6.5 milli... | medcitynew... |
| - | Science 37 raises a $29M Series C for “site-less” clinical t... | Science 37 cofounders Belinda Tan and Noah Craft
If you’re not quite sure what healthcare “convergen... | medcitynew... |
| - | Bracket acquisition underscores the push to make clinical tr... | The patient-centered clinical trial has been a favorite turn of phrase for the pharma and contract r... | medcitynew... |
| - | This is how AI will shape drug discovery | As healthcare venture capitalists, we specialize in technologies that have the potential to transfor... | medcitynew... |
| - | B Capital Group Partner: Pharma value chain will be area of ... | At the intersection of the drug price debate and tax reform, B Capital Group Partner Gavin Teo sees ... | medcitynew... |
